Litcius/Paper detail

Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)

Günter Emons, Jae‐Weon Kim, Karin Weide, Nikolaus de Gregorio, Pauline Wimberger, Fabian Trillsch, Boris Gabriel, Dominik Denschlag, Stefan Kommoss, Mustafa Aydoğdu, Thomas Papathemelis, Martina Gropp‐Meier, Mustafa Zelal Muallem, Cristin Kühn, Andreas Müller, Matthias Frank, Michael Weigel, Holger Bronger, Björn Lampe, Jörn Rau, Carmen Schade‐Brittinger, Philipp Harter

2021International Journal of Gynecological Cancer40 citationsDOI

Topics & Concepts

MedicineEndometrial cancerLymphadenectomyStage (stratigraphy)CancerGynecologyRadiologyInternal medicinePaleontologyBiologyEndometrial and Cervical Cancer TreatmentsGynecological conditions and treatmentsLymphatic System and Diseases
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6) | Litcius